Default Category
-
Immuno-Genetics Inc.: Technology for Predicting Immune Response
Thomas FunkCase IVEY-9B16A061-EEntrepreneurship, MarketingResearchers at the Ontario Veterinary College had formed a company, Immuno-Genetics Inc., to develop new technologies to measure the immune response of dairy cows by using a blood test and skin thickness test on individual cows. Cows who showed a high immune response were unlikely to contract a number of common diseases. The test results thus allowed dairy producers to determine the likelihood of cows having health problems over their lifetimes. ...Starting at €8.20
-
K9FuelBar: An Energy Treat for Dogs
Thomas Funk; Carol HutchinsonCase IVEY-9B17A017-EEntrepreneurship, MarketingIn 2015, a nutritionist and dog lover developed a new canine energy bar called K9FuelBar. This product was made of all-natural, non-genetically modified, organic ingredients. In doing some investigation, the product's developer realized there could be a small, but sufficient, market to make her product commercially viable. At this point, she needed to evaluate and decide on the best method of distribution for her product. She identified multiple ...Starting at €8.20
-
The Heat is ON
Mark Zbaracki; Maziar RazCase IVEY-9B14M097-EEntrepreneurship, StrategyIn January 2014, the chief executive officer of AutoTherm, a small smart-thermostat design company located in Toronto, Canada, was considering the company’s future in light of the uncertainties and fast changing dynamics of the industry. As an incumbent and small engineering firm, AutoTherm’s plans to sell its first product, B133, through partnership with a large electronics company had not been quite successful. Given the dire state of the compa...Starting at €8.20
-
Hoffmann-La Roche: Pricing the Zelboraf Melanoma Treatment for Canada
Mark Zbaracki; Jedy WangCase IVEY-9B16M138-EStrategyThe Canadian brand manager of Zelboraf had to decide how to introduce and price Zelboraf in the Canadian market. Zelboraf was a breakthrough discovery in treatment for melanoma cancer patients. Hoffmann-La Roche (Roche) began developing Zelboraf in 2005. During the clinical trials, the drug yielded such positive results in targeting late-stage (metastatic) melanoma cancer that Roche ended clinical trials early in order to expedite FDA approval an...Starting at €8.20
-
Le Cerf de Tremblant
Thomas Funk; Wendy Lange-FariaCase IVEY-9B13A037-EEntrepreneurship, MarketingAn owner was concerned about the condo she bought in Mont Tremblant, Quebec in 2006 as an investment property and for occasional use by her family. A beautiful, five-bedroom unit with a panoramic view over the La Bête golf course, it was close to the ski area, the village of Tremblant, shopping, spas, restaurants and a casino. It was fully furnished with many upgrades. However, by 2010, the number of rentals was disappointing, and the unit was op...Starting at €8.20